The effective active ingredients of JP (such as quercetin and luteolin) can affect multiple signaling pathways related to the disease by acting on core targets (such as MAPK1 and TP53) to treat SLE-GIOP. The gene discussed is TP53; the disease is systemic lupus erythematosus.